Name | Number of supported studies | Average coverage | |
---|---|---|---|
transit amplifying cell | 3 studies | 22% ± 7% |
Insufficient scRNA-seq data for expression of MCM10 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 92% | 190.95 | 420 / 459 | 85% | 9.76 | 955 / 1118 |
skin | 86% | 423.24 | 1558 / 1809 | 87% | 7.21 | 410 / 472 |
lung | 67% | 67.46 | 385 / 578 | 85% | 8.36 | 984 / 1155 |
intestine | 54% | 79.46 | 519 / 966 | 94% | 8.38 | 494 / 527 |
esophagus | 47% | 141.05 | 679 / 1445 | 97% | 11.12 | 177 / 183 |
stomach | 43% | 58.58 | 155 / 359 | 93% | 8.29 | 267 / 286 |
ovary | 39% | 28.06 | 71 / 180 | 91% | 6.93 | 393 / 430 |
bladder | 33% | 22.00 | 7 / 21 | 92% | 9.77 | 463 / 504 |
uterus | 14% | 10.81 | 23 / 170 | 97% | 13.14 | 446 / 459 |
tonsil | 0% | 0 | 0 / 0 | 100% | 14.06 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.99 | 1 / 1 |
adipose | 98% | 244.36 | 1180 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 14.40 | 28 / 29 |
spleen | 95% | 201.15 | 230 / 241 | 0% | 0 | 0 / 0 |
thymus | 77% | 76.98 | 501 / 653 | 14% | 1.45 | 86 / 605 |
muscle | 63% | 55.81 | 505 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 61% | 529.59 | 571 / 929 | 0% | 0 | 0 / 0 |
liver | 19% | 28.49 | 43 / 226 | 38% | 2.01 | 155 / 406 |
pancreas | 7% | 3.80 | 24 / 328 | 48% | 2.41 | 86 / 178 |
adrenal gland | 37% | 24.49 | 95 / 258 | 17% | 0.86 | 38 / 230 |
brain | 6% | 3.51 | 158 / 2642 | 47% | 3.34 | 330 / 705 |
blood vessel | 33% | 18.15 | 434 / 1335 | 0% | 0 | 0 / 0 |
prostate | 25% | 15.06 | 61 / 245 | 8% | 0.31 | 38 / 502 |
kidney | 17% | 19.36 | 15 / 89 | 11% | 0.48 | 100 / 901 |
heart | 11% | 7.27 | 96 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 8% | 0.19 | 6 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006974 | Biological process | DNA damage response |
GO_0008283 | Biological process | cell population proliferation |
GO_0006270 | Biological process | DNA replication initiation |
GO_0043596 | Cellular component | nuclear replication fork |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0019899 | Molecular function | enzyme binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0003697 | Molecular function | single-stranded DNA binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0003688 | Molecular function | DNA replication origin binding |
Gene name | MCM10 |
Protein name | Protein MCM10 homolog (HsMCM10) Protein MCM10 homolog Minichromosome maintenance 10 replication initiation factor |
Synonyms | PRO2249 hCG_40780 |
Description | FUNCTION: Acts as a replication initiation factor that brings together the MCM2-7 helicase and the DNA polymerase alpha/primase complex in order to initiate DNA replication. Additionally, plays a role in preventing DNA damage during replication. Key effector of the RBBP6 and ZBTB38-mediated regulation of DNA-replication and common fragile sites stability; acts as a direct target of transcriptional repression by ZBTB38 . . |
Accessions | ENST00000378694.1 ENST00000479669.5 ENST00000378714.8 [Q7L590-2] C9J600 Q5T670 ENST00000484800.6 [Q7L590-1] Q7L590 |